{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T20:36:52Z","timestamp":1794083812993,"version":"4.8.0"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["AAPS PharmSciTech"],"published-print":{"date-parts":[[2021,4]]},"DOI":"10.1208\/s12249-021-01986-z","type":"journal-article","created":{"date-parts":[[2021,4,2]],"date-time":"2021-04-02T17:02:48Z","timestamp":1617382968000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Coating characterization by hyperspectroscopy and predictive dissolution models of tablets coated with blends of cellulose acetate and cellulose acetate phthalate"],"prefix":"10.1208","volume":"22","author":[{"given":"Tahir","family":"Khuroo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eman M.","family":"Mohamed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sathish","family":"Dharani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hamideh","family":"Afrooz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sogra F.","family":"Barakh Ali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Phillip","family":"Cook","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mansoor A.","family":"Khan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0402-825X","authenticated-orcid":false,"given":"Ziyaur","family":"Rahman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,4,2]]},"reference":[{"issue":"3-4","key":"1986_CR1","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1159\/000492079","volume":"102","author":"E \u010ce\u0161kov\u00e1","year":"2018","unstructured":"\u010ce\u0161kov\u00e1 E, \u0160edov\u00e1 M, Kellnerov\u00e1 R, Starobov\u00e1 O. Once-a-day trazodone in the treatment of depression in routine clinical practice. Pharmacology. 2018;102(3-4):206\u201312.","journal-title":"Pharmacology."},{"issue":"4","key":"1986_CR2","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1007\/s13318-018-0461-2","volume":"43","author":"M Wang","year":"2018","unstructured":"Wang M, Wang M, Zhang Q, Zong S, Lv C. Pharmacokinetics and safety of levetiracetam extended-release tablets and relative bioavailability compared with immediate-release tablets in healthy Chinese subjects. Eur J Drug Metab Pharmacokinet. 2018;43(4):405\u201313.","journal-title":"Eur J Drug Metab Pharmacokinet"},{"key":"1986_CR3","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1016\/j.amjsurg.2020.02.027","volume":"219","author":"J Torabi","year":"2020","unstructured":"Torabi J, Konicki A, Rocca JP, Ajaimy M, Campbell A, Azzi Y, et al. Utilization of LCP-Tacrolimus (Envarsus XR) in simultaneous pancreas and kidney (SPK) transplant recipients. Am J Surg. 2020;219:583\u20136.","journal-title":"Am J Surg"},{"issue":"1","key":"1986_CR4","doi-asserted-by":"publisher","first-page":"e13767","DOI":"10.1111\/ctr.13767","volume":"34","author":"A S\u00e1nchez Fructuoso","year":"2020","unstructured":"S\u00e1nchez Fructuoso A, Ruiz JC, Franco A, Diekmann F, Redondo D, Calvi\u00f1o J, et al. Effectiveness and safety of the conversion to MeltDose\u00ae extended-release tacrolimus from other formulations of tacrolimus in stable kidney transplant patients: A retrospective study. Clin Transpl. 2020;34(1):e13767.","journal-title":"Clin Transpl"},{"issue":"3","key":"1986_CR5","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1080\/14656566.2018.1549543","volume":"20","author":"M Banach","year":"2019","unstructured":"Banach M, Miziak B, Borowicz-Reutt KK, Czuczwar SJ. Advances with extended and controlled release formulations of antiepileptics in the elderly. Expert Opin Pharmacother. 2019;20(3):333\u201341.","journal-title":"Expert Opin Pharmacother"},{"issue":"4","key":"1986_CR6","doi-asserted-by":"publisher","first-page":"1090","DOI":"10.1021\/acs.molpharmaceut.9b01063","volume":"17","author":"FD Zahoor","year":"2020","unstructured":"Zahoor FD, Mader KT, Timmins P, Brown J, Sammon C. Investigation of within-tablet dynamics for extended release of a poorly soluble basic drug from hydrophilic matrix tablets using ATR\u2013FTIR imaging. Mol Pharm. 2020;17(4):1090\u20139.","journal-title":"Mol Pharm"},{"issue":"3","key":"1986_CR7","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1080\/03639045.2020.1716372","volume":"46","author":"R Gundu","year":"2020","unstructured":"Gundu R, Pekamwar S, Shelke S, Shep S, Kulkarni D. Sustained release formulation of Ondansetron HCl using osmotic drug delivery approach. Drug Dev Ind Pharm. 2020;46(3):343\u201355.","journal-title":"Drug Dev Ind Pharm"},{"key":"1986_CR8","unstructured":"Depakote ER FDA label. Accessed on June 23, 2020 https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2020\/021168s041lbl.pdf."},{"key":"1986_CR9","unstructured":"Tegretol\u00ae-XR FDA label. Accessed on June 23, 2020. https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2018\/016608s115_018281_s058_018927s055_020234_s047.pdf."},{"key":"1986_CR10","unstructured":"Concerta\u00ae FDA label. Accessed on June 23, 2020. https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2017\/021121s038lbl.pdf."},{"key":"1986_CR11","unstructured":"Embeda\u00ae FDA label. Accessed on June 23, 2020. https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2019\/022321s030lbl.pdf."},{"key":"1986_CR12","unstructured":"Aggrenox\u00ae FDA label. Accessed on June 23, 2020. https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2019\/020884s039lbledt.pdf."},{"key":"1986_CR13","doi-asserted-by":"publisher","first-page":"118462","DOI":"10.1016\/j.ijpharm.2019.118462","volume":"567","author":"SF Ali","year":"2019","unstructured":"Ali SF, Afrooz H, Hampel R, Mohamed EM, Bhattacharya R, Cook P, et al. Blend of cellulose ester and enteric polymers for delayed and enteric coating of core tablets of hydrophilic and hydrophobic drugs. Int J Pharm. 2019;567:118462.","journal-title":"Int J Pharm"},{"issue":"3","key":"1986_CR14","doi-asserted-by":"publisher","first-page":"234","DOI":"10.3390\/pharmaceutics12030234","volume":"12","author":"C Mwila","year":"2020","unstructured":"Mwila C, Walker RB. Improved Stability of Rifampicin in the Presence of Gastric-Resistant Isoniazid Microspheres in Acidic Media. Pharmaceutics. 2020;12(3):234.","journal-title":"Pharmaceutics."},{"key":"1986_CR15","unstructured":"Eudragit\u00ae. Accessed on June 23, 2020. https:\/\/healthcare.evonik.com\/sites\/lists\/NC\/DocumentsHC\/Evonik-Eudragit_brochure.pdf."},{"issue":"4","key":"1986_CR16","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1023\/A:1027359708581","volume":"10","author":"H Sato","year":"2003","unstructured":"Sato H, Uraki Y, Kishimoto T, Sano Y. New process for producing cellulose acetate from wood in concentrated acetic acid. Cellulose. 2003;10(4):397\u2013404.","journal-title":"Cellulose."},{"issue":"1","key":"1986_CR17","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1007\/s10924-010-0258-0","volume":"19","author":"J Puls","year":"2011","unstructured":"Puls J, Wilson SA, H\u00f6lter D. Degradation of cellulose acetate-based materials: a review. J Polym Environ. 2011;19(1):152\u201365.","journal-title":"J Polym Environ"},{"key":"1986_CR18","unstructured":"FDA Inactive ingredients database. Accessed on June 24, 2020. https:\/\/www.accessdata.fda.gov\/scripts\/cder\/iig\/index.cfm?event=BasicSearch.page."},{"key":"1986_CR19","unstructured":"USP43-NF38 \u2013 Cellulose acetate, page 5701, 2020."},{"issue":"7","key":"1986_CR20","doi-asserted-by":"publisher","first-page":"509","DOI":"10.3109\/10717544.2013.853209","volume":"21","author":"OP Ranjan","year":"2014","unstructured":"Ranjan OP, Nayak UY, Reddy MS, Dengale SJ, Musmade PB, Udupa N. Osmotically controlled pulsatile release capsule of montelukast sodium for chronotherapy: statistical optimization, in vitro and in vivo evaluation. Drug Deliv. 2014;21(7):509\u201318.","journal-title":"Drug Deliv"},{"issue":"1","key":"1986_CR21","doi-asserted-by":"publisher","first-page":"1986","DOI":"10.3762\/bjnano.9.189","volume":"9","author":"AR Tsiapla","year":"2018","unstructured":"Tsiapla AR, Karagkiozaki V, Bakola V, Pappa F, Gkertsiou P, Pavlidou E, et al. Biomimetic and biodegradable cellulose acetate scaffolds loaded with dexamethasone for bone implants. Beilstein J Nanotechnol. 2018;9(1):1986\u201394.","journal-title":"Beilstein J Nanotechnol"},{"issue":"7","key":"1986_CR22","doi-asserted-by":"publisher","first-page":"2636","DOI":"10.1002\/jbm.b.34080","volume":"106","author":"V Guarino","year":"2018","unstructured":"Guarino V, Caputo T, Calcagnile P, Altobelli R, Demitri C, Ambrosio L. Core\/shell cellulose-based microspheres for oral administration of Ketoprofen Lysinate. J Biomed Mater Res B Appl Biomater. 2018;106(7):2636\u201344.","journal-title":"J Biomed Mater Res B Appl Biomater"},{"issue":"4","key":"1986_CR23","doi-asserted-by":"publisher","first-page":"520","DOI":"10.3390\/molecules21040520","volume":"21","author":"IL Liakos","year":"2016","unstructured":"Liakos IL, Abdellatif MH, Innocenti C, Scarpellini A, Carzino R, Brunetti V, et al. Antimicrobial lemongrass essential oil\u2014copper ferrite cellulose acetate nanocapsules. Molecules. 2016;21(4):520.","journal-title":"Molecules."},{"issue":"2","key":"1986_CR24","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1016\/j.ijpharm.2016.01.060","volume":"510","author":"IL Liakos","year":"2016","unstructured":"Liakos IL, D\u2019autilia F, Garzoni A, Bonferoni C, Scarpellini A, Brunetti V, et al. All natural cellulose acetate\u2014Lemongrass essential oil antimicrobial nanocapsules. Int J Pharm. 2016;510(2):508\u201315.","journal-title":"Int J Pharm"},{"key":"1986_CR25","doi-asserted-by":"publisher","first-page":"107978","DOI":"10.1016\/j.carres.2020.107978","volume":"5","author":"MA Wsoo","year":"2020","unstructured":"Wsoo MA, Shahir S, Bohari SP, Nayan NH, Abd Razak SI. A review on the properties of electrospun cellulose acetate and its application in drug delivery systems: A new perspective. Carbohydr Res. 2020s;5:107978.","journal-title":"Carbohydr Res"},{"issue":"3","key":"1986_CR26","first-page":"1","volume":"21","author":"SF Ali","year":"2020","unstructured":"Ali SF, Dharani S, Afrooz H, Mohamed EM, Cook P, Khan MA, et al. Development of Abuse-Deterrent Formulations Using Sucrose Acetate Isobutyrate. AAPS PharmSciTech. 2020;21(3):1\u20134.","journal-title":"AAPS PharmSciTech"},{"key":"1986_CR27","unstructured":"Voltaren\u00ae-XR FDA label. Accessed on March 03, 2021. https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2016\/020254s028lbl.pdf."},{"key":"1986_CR28","unstructured":"Voltaren\u00ae FDA label. Accessed on March 03, 2021. https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2016\/019201s046lbl.pdf."},{"issue":"1-2","key":"1986_CR29","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1016\/j.ijpharm.2018.07.042","volume":"550","author":"Z Rahman","year":"2018","unstructured":"Rahman Z, Dharani S, Ali SF, Afrooz H, Reddy IK, Khan MA. Effect of processing parameters and controlled environment storage on the disproportionation and dissolution of extended-release capsule of phenytoin sodium. Int J Pharm. 2018;550(1-2):290\u20139.","journal-title":"Int J Pharm"},{"key":"1986_CR30","unstructured":"ICH harmonized tripartite guideline\u2014Validation of analytical procedures: Text and methodology Q2 (R1), 2005."},{"issue":"1-2","key":"1986_CR31","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1016\/j.ijpharm.2018.02.013","volume":"540","author":"T Sakai","year":"2018","unstructured":"Sakai T, Hirai D, Kimura SI, Iwao Y, Itai S. Effects of tablet formulation and subsequent film coating on the supersaturated dissolution behavior of amorphous solid dispersions. Int J Pharm. 2018;540(1-2):171\u20137.","journal-title":"Int J Pharm"},{"issue":"1","key":"1986_CR32","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1111\/j.2042-7158.1982.tb04667.x","volume":"34","author":"SC Porter","year":"1982","unstructured":"Porter SC, Ridgway K. The permeability of enteric coatings and the dissolution rates of coated tablets. J Pharm Pharmacol. 1982;34(1):5\u20138.","journal-title":"J Pharm Pharmacol"},{"issue":"1","key":"1986_CR33","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/j.ejpb.2006.09.001","volume":"66","author":"S Chopra","year":"2007","unstructured":"Chopra S, Patil GV, Motwani SK. Release modulating hydrophilic matrix systems of losartan potassium: Optimization of formulation using statistical experimental design. Eur J Pharm Biopharm. 2007;66(1):73\u201382.","journal-title":"Eur J Pharm Biopharm"},{"issue":"3","key":"1986_CR34","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1021\/mp400484g","volume":"11","author":"Z Rahman","year":"2014","unstructured":"Rahman Z, Xu X, Katragadda U, Krishnaiah YS, Yu L, Khan MA. Quality by design approach for understanding the critical quality attributes of cyclosporine ophthalmic emulsion. Mol Pharm. 2014;11(3):787\u201399.","journal-title":"Mol Pharm"},{"issue":"2","key":"1986_CR35","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1208\/s12249-015-0377-y","volume":"17","author":"R Wulff","year":"2016","unstructured":"Wulff R, Leopold CS. Coatings of Eudragit\u00ae RL and L-55 blends: investigations on the drug release mechanism. AAPS PharmSciTech. 2016;17(2):493\u2013503.","journal-title":"AAPS PharmSciTech"},{"issue":"5","key":"1986_CR36","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1016\/j.ajps.2013.10.002","volume":"8","author":"Y Hou","year":"2013","unstructured":"Hou Y, Wang H, Zhang X, Zou M, Cheng G. Study of the mechanism of cationic drug release increase coated with Surelease\u00ae after curing. Asian J Pharm Sci. 2013;8(5):295\u2013302.","journal-title":"Asian J Pharm Sci"},{"key":"1986_CR37","unstructured":"EastmanTM Cellulose acetate (CA 398-10 NF\/EP)\u2014Technical datasheet. Accessed on July 07, 2020. https:\/\/productcatalog.eastman.com\/tds\/ProdDatasheet.aspx?product=71051329&pn=Cellulose+Acetate+-+CA-398-10NF%2fEP+(National+Formulary+and+European+Pharmacopoeia)#_ga=2.161618940.1511400293.1594055117-1166129648.1591652891."},{"key":"1986_CR38","unstructured":"EastmanTM Cellulose acetate (CA 320S NF\/EP)\u2014Technical datasheet. Accessed on July 07, 2020. https:\/\/productcatalog.eastman.com\/tds\/ProdDatasheet.aspx?product=71063628&pn=Cellulose+Acetate+-+CA-320S+NF%2fEP+(National+Formulary+and+European+Pharmacopoeia)#_ga=2.161618940.1511400293.1594055117-1166129648.1591652891."},{"issue":"12","key":"1986_CR39","doi-asserted-by":"publisher","first-page":"1375","DOI":"10.1002\/jps.2600711216","volume":"71","author":"N Sarisuta","year":"1982","unstructured":"Sarisuta N, Parrott EL. Relationship of dissolution rate to viscosity of polymeric solutions. J Pharm Sci. 1982;71(12):1375\u201380.","journal-title":"J Pharm Sci"}],"container-title":["AAPS PharmSciTech"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1208\/s12249-021-01986-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1208\/s12249-021-01986-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1208\/s12249-021-01986-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,6]],"date-time":"2021-05-06T18:35:06Z","timestamp":1620326106000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1208\/s12249-021-01986-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4]]},"references-count":39,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2021,4]]}},"alternative-id":["1986"],"URL":"https:\/\/doi.org\/10.1208\/s12249-021-01986-z","relation":{},"ISSN":["1530-9932"],"issn-type":[{"value":"1530-9932","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,4]]},"assertion":[{"value":"23 January 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 March 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 April 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"122"}}